EP3409274
Skömmtunaráætlun fyrir S1P-Viðtakaörva
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
21.12.2009EP published:
20.11.2019EP application number:
18179301.9
EP translation filed:
5.12.2019Grant published:
15.12.2019EPO information:
European Patent Register
Max expiry date:
20.12.2029Expiry date:
20.12.2025
Title:
DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
Timeline
Today
21.12.2009EP application
20.11.2019EP Publication
5.12.2019Translation submitted
15.12.2019Registration published
20.12.2025Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
Schmouder, RobertAddress:
East Hanover, New Jersey, US
Name:
Dumortier, ThomasAddress:
Basel, CH
Name:
David, OlivierAddress:
Basel, CH
Name:
Looby, MichaelAddress:
Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
139672 PDate:
22.12.2008Country:
US
Number:
218530 PDate:
19.6.2009Country:
US
Number:
246715 PDate:
29.9.2009Country:
US
Supplementary protection
SPC number:
SPC319
Classification
Categories:
A61K 31/137, A61P 37/00, A61P 37/06, A61K 31/135, A61K 31/138, A61K 31/661
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 18.2.2020
Expires: 20.12.2020
Payer: Árnason Faktor ehf.
Number: 12
Paid: 24.11.2020
Expires: 20.12.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 24.11.2021
Expires: 20.12.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 30.11.2022
Expires: 20.12.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 12.12.2023
Expires: 20.12.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 28.11.2024
Expires: 20.12.2025
Payer: Árnason Faktor ehf.